Global Sexually Transmitted Disease Therapeutics Market Research Report 2023

Sexually transmitted diseases are infections that are passed from one person to another through sexual contact.

The global Sexually Transmitted Disease Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Sexually Transmitted Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Sexually Transmitted Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Sexually Transmitted Disease Therapeutics in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Sexually Transmitted Disease Therapeutics include Abbott, Roche, BD, BioMérieux, Bio-Rad and Cepheid, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Disease Therapeutics.

The Sexually Transmitted Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Sexually Transmitted Disease Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sexually Transmitted Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Gonorrhea

1.2.3 Syphilis

1.2.4 Chlamydia

1.2.5 Trichomoniasis

1.3 Market by Application

1.3.1 Global Sexually Transmitted Disease Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Diagnostic Laboratories

1.3.4 Research and Academic Laboratories

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Sexually Transmitted Disease Therapeutics Market Perspective (2018-2029)

2.2 Sexually Transmitted Disease Therapeutics Growth Trends by Region

2.2.1 Global Sexually Transmitted Disease Therapeutics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Sexually Transmitted Disease Therapeutics Historic Market Size by Region (2018-2023)

2.2.3 Sexually Transmitted Disease Therapeutics Forecasted Market Size by Region (2024-2029)

2.3 Sexually Transmitted Disease Therapeutics Market Dynamics

2.3.1 Sexually Transmitted Disease Therapeutics Industry Trends

2.3.2 Sexually Transmitted Disease Therapeutics Market Drivers

2.3.3 Sexually Transmitted Disease Therapeutics Market Challenges

2.3.4 Sexually Transmitted Disease Therapeutics Market Restraints

3.1 Global Top Sexually Transmitted Disease Therapeutics Players by Revenue

3.1.1 Global Top Sexually Transmitted Disease Therapeutics Players by Revenue (2018-2023)

3.1.2 Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Players (2018-2023)

3.2 Global Sexually Transmitted Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Sexually Transmitted Disease Therapeutics Revenue

3.4 Global Sexually Transmitted Disease Therapeutics Market Concentration Ratio

3.4.1 Global Sexually Transmitted Disease Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease Therapeutics Revenue in 2022

3.5 Sexually Transmitted Disease Therapeutics Key Players Head office and Area Served

3.6 Key Players Sexually Transmitted Disease Therapeutics Product Solution and Service

3.7 Date of Enter into Sexually Transmitted Disease Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Sexually Transmitted Disease Therapeutics Historic Market Size by Type (2018-2023)

4.2 Global Sexually Transmitted Disease Therapeutics Forecasted Market Size by Type (2024-2029)

5.1 Global Sexually Transmitted Disease Therapeutics Historic Market Size by Application (2018-2023)

5.2 Global Sexually Transmitted Disease Therapeutics Forecasted Market Size by Application (2024-2029)

6.1 North America Sexually Transmitted Disease Therapeutics Market Size (2018-2029)

6.2 North America Sexually Transmitted Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Sexually Transmitted Disease Therapeutics Market Size by Country (2018-2023)

6.4 North America Sexually Transmitted Disease Therapeutics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Sexually Transmitted Disease Therapeutics Market Size (2018-2029)

7.2 Europe Sexually Transmitted Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Sexually Transmitted Disease Therapeutics Market Size by Country (2018-2023)

7.4 Europe Sexually Transmitted Disease Therapeutics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Size (2018-2029)

8.2 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Size by Region (2018-2023)

8.4 Asia-Pacific Sexually Transmitted Disease Therapeutics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Sexually Transmitted Disease Therapeutics Market Size (2018-2029)

9.2 Latin America Sexually Transmitted Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Sexually Transmitted Disease Therapeutics Market Size by Country (2018-2023)

9.4 Latin America Sexually Transmitted Disease Therapeutics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size (2018-2029)

10.2 Middle East & Africa Sexually Transmitted Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size by Country (2018-2023)

10.4 Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Abbott

11.1.1 Abbott Company Detail

11.1.2 Abbott Business Overview

11.1.3 Abbott Sexually Transmitted Disease Therapeutics Introduction

11.1.4 Abbott Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023)

11.1.5 Abbott Recent Development

11.2 Roche

11.2.1 Roche Company Detail

11.2.2 Roche Business Overview

11.2.3 Roche Sexually Transmitted Disease Therapeutics Introduction

11.2.4 Roche Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023)

11.2.5 Roche Recent Development

11.3 BD

11.3.1 BD Company Detail

11.3.2 BD Business Overview

11.3.3 BD Sexually Transmitted Disease Therapeutics Introduction

11.3.4 BD Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023)

11.3.5 BD Recent Development

11.4 BioMérieux

11.4.1 BioMérieux Company Detail

11.4.2 BioMérieux Business Overview

11.4.3 BioMérieux Sexually Transmitted Disease Therapeutics Introduction

11.4.4 BioMérieux Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023)

11.4.5 BioMérieux Recent Development

11.5 Bio-Rad

11.5.1 Bio-Rad Company Detail

11.5.2 Bio-Rad Business Overview

11.5.3 Bio-Rad Sexually Transmitted Disease Therapeutics Introduction

11.5.4 Bio-Rad Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023)

11.5.5 Bio-Rad Recent Development

11.6 Cepheid

11.6.1 Cepheid Company Detail

11.6.2 Cepheid Business Overview

11.6.3 Cepheid Sexually Transmitted Disease Therapeutics Introduction

11.6.4 Cepheid Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023)

11.6.5 Cepheid Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Gonorrhea

    Table 3. Key Players of Syphilis

    Table 4. Key Players of Chlamydia

    Table 5. Key Players of Trichomoniasis

    Table 6. Global Sexually Transmitted Disease Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Sexually Transmitted Disease Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Sexually Transmitted Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Sexually Transmitted Disease Therapeutics Market Share by Region (2018-2023)

    Table 10. Global Sexually Transmitted Disease Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Sexually Transmitted Disease Therapeutics Market Share by Region (2024-2029)

    Table 12. Sexually Transmitted Disease Therapeutics Market Trends

    Table 13. Sexually Transmitted Disease Therapeutics Market Drivers

    Table 14. Sexually Transmitted Disease Therapeutics Market Challenges

    Table 15. Sexually Transmitted Disease Therapeutics Market Restraints

    Table 16. Global Sexually Transmitted Disease Therapeutics Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Sexually Transmitted Disease Therapeutics Market Share by Players (2018-2023)

    Table 18. Global Top Sexually Transmitted Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease Therapeutics as of 2022)

    Table 19. Ranking of Global Top Sexually Transmitted Disease Therapeutics Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Sexually Transmitted Disease Therapeutics Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Sexually Transmitted Disease Therapeutics Product Solution and Service

    Table 23. Date of Enter into Sexually Transmitted Disease Therapeutics Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Sexually Transmitted Disease Therapeutics Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Type (2018-2023)

    Table 27. Global Sexually Transmitted Disease Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Type (2024-2029)

    Table 29. Global Sexually Transmitted Disease Therapeutics Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Application (2018-2023)

    Table 31. Global Sexually Transmitted Disease Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Application (2024-2029)

    Table 33. North America Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Sexually Transmitted Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Sexually Transmitted Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Sexually Transmitted Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Sexually Transmitted Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Sexually Transmitted Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Sexually Transmitted Disease Therapeutics Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Sexually Transmitted Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Sexually Transmitted Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Abbott Company Detail

    Table 49. Abbott Business Overview

    Table 50. Abbott Sexually Transmitted Disease Therapeutics Product

    Table 51. Abbott Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023) & (US$ Million)

    Table 52. Abbott Recent Development

    Table 53. Roche Company Detail

    Table 54. Roche Business Overview

    Table 55. Roche Sexually Transmitted Disease Therapeutics Product

    Table 56. Roche Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023) & (US$ Million)

    Table 57. Roche Recent Development

    Table 58. BD Company Detail

    Table 59. BD Business Overview

    Table 60. BD Sexually Transmitted Disease Therapeutics Product

    Table 61. BD Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023) & (US$ Million)

    Table 62. BD Recent Development

    Table 63. BioMérieux Company Detail

    Table 64. BioMérieux Business Overview

    Table 65. BioMérieux Sexually Transmitted Disease Therapeutics Product

    Table 66. BioMérieux Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023) & (US$ Million)

    Table 67. BioMérieux Recent Development

    Table 68. Bio-Rad Company Detail

    Table 69. Bio-Rad Business Overview

    Table 70. Bio-Rad Sexually Transmitted Disease Therapeutics Product

    Table 71. Bio-Rad Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023) & (US$ Million)

    Table 72. Bio-Rad Recent Development

    Table 73. Cepheid Company Detail

    Table 74. Cepheid Business Overview

    Table 75. Cepheid Sexually Transmitted Disease Therapeutics Product

    Table 76. Cepheid Revenue in Sexually Transmitted Disease Therapeutics Business (2018-2023) & (US$ Million)

    Table 77. Cepheid Recent Development

    Table 78. Research Programs/Design for This Report

    Table 79. Key Data Information from Secondary Sources

    Table 80. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Sexually Transmitted Disease Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Sexually Transmitted Disease Therapeutics Market Share by Type: 2022 VS 2029

    Figure 3. Gonorrhea Features

    Figure 4. Syphilis Features

    Figure 5. Chlamydia Features

    Figure 6. Trichomoniasis Features

    Figure 7. Global Sexually Transmitted Disease Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Sexually Transmitted Disease Therapeutics Market Share by Application: 2022 VS 2029

    Figure 9. Hospitals Case Studies

    Figure 10. Diagnostic Laboratories Case Studies

    Figure 11. Research and Academic Laboratories Case Studies

    Figure 12. Others Case Studies

    Figure 13. Sexually Transmitted Disease Therapeutics Report Years Considered

    Figure 14. Global Sexually Transmitted Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Sexually Transmitted Disease Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Sexually Transmitted Disease Therapeutics Market Share by Region: 2022 VS 2029

    Figure 17. Global Sexually Transmitted Disease Therapeutics Market Share by Players in 2022

    Figure 18. Global Top Sexually Transmitted Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Disease Therapeutics as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Sexually Transmitted Disease Therapeutics Revenue in 2022

    Figure 20. North America Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Sexually Transmitted Disease Therapeutics Market Share by Country (2018-2029)

    Figure 22. United States Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Sexually Transmitted Disease Therapeutics Market Share by Country (2018-2029)

    Figure 26. Germany Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Sexually Transmitted Disease Therapeutics Market Share by Region (2018-2029)

    Figure 34. China Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Sexually Transmitted Disease Therapeutics Market Share by Country (2018-2029)

    Figure 42. Mexico Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Share by Country (2018-2029)

    Figure 46. Turkey Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Sexually Transmitted Disease Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Abbott Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2018-2023)

    Figure 49. Roche Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2018-2023)

    Figure 50. BD Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2018-2023)

    Figure 51. BioMérieux Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2018-2023)

    Figure 52. Bio-Rad Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2018-2023)

    Figure 53. Cepheid Revenue Growth Rate in Sexually Transmitted Disease Therapeutics Business (2018-2023)

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed